Tango Therapeutics CEO Barbara Weber's 2021 pay jumps 1,102% to $12M
Tango Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 26, 2022
Tango Therapeutics reported fiscal year 2021 executive compensation information on April 26, 2022.
In 2021, three executives at Tango Therapeutics received on average a compensation package of $5.6M, a 610% increase compared to previous year.
Average pay of disclosed executives at Tango Therapeutics
Barbara Weber, Chief Executive Officer, received $12M in total, which increased by 1,102% compared to 2020. 93% of Weber's compensation, or $11M, was in option awards. Weber also received $278K in non-equity incentive plan, $514K in salary, as well as $4.6K in other compensation.
Daniella Beckman, Chief Financial Officer, received a compensation package of $3.2M, which increased by 281% compared to previous year. 83% of the compensation package, or $2.6M, was in option awards.
Alan Huang, Chief Scientific Officer, earned $2.2M in 2021, a 276% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 26, 2022.